SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001144204-19-022376
Filing Date
2019-04-30
Accepted
2019-04-30 16:11:09
Documents
10
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A tv519971_10ka.htm 10-K/A 453633
2 EXHIBIT 31.1 tv519971_ex31-1.htm EX-31.1 2986
3 EXHIBIT 31.2 tv519971_ex31-2.htm EX-31.2 2934
4 GRAPHIC tv519971_img01.jpg GRAPHIC 9806
5 GRAPHIC tv519971_img02.jpg GRAPHIC 8770
6 GRAPHIC tv519971_img03.jpg GRAPHIC 11575
7 GRAPHIC tv519971_img04.jpg GRAPHIC 11575
8 GRAPHIC tv519971_img05.jpg GRAPHIC 10755
9 GRAPHIC tv519971_img06.jpg GRAPHIC 2458
10 GRAPHIC tv519971_img07.jpg GRAPHIC 2491
  Complete submission text file 0001144204-19-022376.txt   540677
Mailing Address 20 FIRSTFIELD ROAD GAITHERSBURG MD 20878
Business Address 20 FIRSTFIELD ROAD GAITHERSBURG MD 20878 240-268-2000
NOVAVAX INC (Filer) CIK: 0001000694 (see all company filings)

IRS No.: 222816046 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-26770 | Film No.: 19781805
SIC: 2836 Biological Products, (No Diagnostic Substances)